About New Science Ventures
Investments are channeled by New Science Ventures into early, mid, and late-stage companies operating in pharmaceuticals, biologics, medical devices, cellular infrastructure, and sensor networks. Geographic focus is placed on the US, Europe, India, and China. Portfolio holdings include Ferric, Caringo, Ovizio, and Kateeva. Operations are headquartered in New York, United States, with emphasis on venture capital funding for innovative technologies.
- Headquarter New York, United States
- Website newscienceventures.com
People of New Science Ventures
7 people are tracked at New Science Ventures (6 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Somu Subramaniam | Managing Partner | Leadership |
Brenda Marex | Partner & CFO | Leadership |
Tom Lavin | Partner | Leadership |
Jean-Pierre Bizet | Partner & Senior Advisor | Leadership |
Andrew Abrams | Partner | Leadership |
Raju Mohan | Partner & Senior Advisor | Leadership |
Jonny He | Controller | Team |
Complete people profiles for New Science Ventures
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about New Science Ventures
New Science Ventures is headquartered in New York, United States. It is registered at New York, New York, United States.
Investments are channeled by New Science Ventures into early, mid, and late-stage companies operating in pharmaceuticals, biologics, medical devices, cellular infrastructure, and sensor networks. Geographic focus is placed on the US, Europe, India, and China. Portfolio holdings include Ferric, Caringo, Ovizio, and Kateeva. Operations are headquartered in New York, United States, with emphasis on venture capital funding for innovative technologies.